Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of DLBS2411 Compared to Omeprazole in the Management of Gastroesophageal Reflux Disease (GERD)

NCT03367195 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT03367195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of DLBS2411 Compared to Omeprazole in the Management of Gastroesophageal Reflux Disease (GERD)
Lead sponsor
Dexa Medica Group
Phase
Phase 3
Overall status
Terminated
Start date
August 16, 2018
Completion date
September 9, 2020
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease (gerd)